Post-earnings recap
Reported
Wed, Jul 29, 2026
EPS actual
$7.61
EPS est.
$6.22
EPS surprise
+22.27%
1-day move
-5.99%
Humana Inc. reported a strong earnings per share that significantly exceeded expectations, indicating strong performance in that area. However, the stock fell nearly 6% in reaction, which may reflect investor concerns or profit-taking despite the positive EPS surprise. The lack of revenue data and management commentary may also have contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $7.61 | $-1.01 | +22.27% |
| Revenue | N/A | $40.9B | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Humana Inc. is a leading health care company that provides managed health care services. With a focus on health insurance and wellness solutions, Humana plays a crucial role in the health care sector, especially as demand for health services continues to grow amid an aging population and rising health care costs.
Last quarter
In Q1-2026, Humana reported an EPS of $10.31, beating estimates by 3.46%. The stock reacted positively, increasing by 5.83% the next day.
Management promises and guidance
EPS beat streak
4Q
EPS beat rate
88%
Avg EPS surprise
+9.64%
Avg 1-day reaction
+0.48%
Analysts are cautiously optimistic ahead of Humana's earnings report, with expectations for a loss in EPS but stable revenue figures. The market is closely watching how the company navigates ongoing challenges in the health care sector.
Bull case
If Humana manages to outperform expectations, particularly in revenue, it could signal strong operational efficiency and customer retention, leading to a positive stock reaction.
Bear case
Conversely, a larger-than-expected loss in EPS could raise concerns about the company's financial health and operational challenges, potentially leading to a negative market reaction.
Key metrics to watch
EPS
$-1.01Earnings per share is a key indicator of profitability and will show how well the company is managing costs and revenues.
Revenue
$40.9BTotal revenue reflects the company's ability to attract and retain customers, which is vital for growth in the competitive health care market.
The print will turn on these.
Q1
Will Humana's EPS come in better than the consensus estimate of $-1.01?
A better-than-expected EPS could indicate improved cost management and operational efficiency, which would be crucial for investor confidence.
Q2
How will revenue compare to the consensus of $40.9B?
Revenue performance is critical for assessing the company's growth trajectory and market position, especially in a competitive landscape.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±3.5%
Why consensus could be wrong
The consensus may be underestimating Humana's ability to manage costs effectively, which could lead to a smaller EPS loss than expected.
Supporting evidence
Humana has a strong track record of beating EPS estimates, with an 88% beat rate over the last eight quarters.
The recent positive trend in customer satisfaction could translate into better revenue performance than analysts anticipate.
Key risk
If the EPS loss is significantly less than $-1.01, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is particularly important as it reflects how well Humana is managing costs and maintaining revenue in a challenging health care environment.
Bull confirmed if
An EPS of better than $-0.96 would confirm the bull case, indicating stronger-than-expected operational performance.
Bear confirmed if
An EPS worse than $-1.09 would confirm the bear case, raising concerns about financial stability.
What the market is pricing for the move.
Implied Move
±18.35%
Historical Avg
±5.2%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±18.4% while HUM has averaged ±5.2% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
45.5%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
100.95%
of float
Insider
0.21%
of float
Holders
1,304
institutions
Top Holders· as of Jun 2026
Dodge & Cox Inc.
10,940,380 sh · $4.3B
9.11%
-3.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Humana beats expectations, history suggests a potential stock increase of around 5.76%, confirming operational strength.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.
Miss
A miss could lead to a significant drop, with historical patterns indicating an average decline of around 12.40% following earnings misses.
The lines on the call that would change the story.
Blackrock Inc.
10,417,803 sh · $4.1B
8.68%
2.1%
Vanguard Capital Management LLC
7,843,620 sh · $3.1B
6.53%
0.1%
Vanguard Portfolio Management LLC
5,818,956 sh · $2.3B
4.85%
0.2%
State Street Corporation
5,457,072 sh · $2.2B
4.54%
0.1%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.